Key result
Intensive lowering of systolic blood pressure to a target of ≤ 120 mm Hg challenges the conventional approach to hypertension care compared to a standard target of ≤ 140 mm Hg.
Why the study?
Does intensive lowering of systolic blood pressure (target ≤ 120 mm Hg) improve outcomes compared to standard treatment (target ≤ 140 mm Hg) in hypertension care?
Does intensive lowering of systolic blood pressure (target ≤ 120 mm Hg) improve outcomes compared to standard treatment (target ≤ 140 mm Hg) in hypertension care?
Discusses the implications of the SPRINT trial's intensive blood pressure lowering strategy on conventional hypertension care.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Rabi et al. (2016) studied this question. Intensive lowering of systolic blood pressure to a target of ≤ 120 mm Hg challenges the conventional approach to hypertension care compared to a standard target of ≤ 140 mm Hg.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: